Risk factors for hospitalization in well-dialyzed chronic hemodialysis patients

被引:19
作者
Becker, BN
Coomer, RW
Fotiadis, C
Evanson, J
Shyr, Y
Hakim, RM
机构
[1] Univ Wisconsin, Ctr Clin Sci H4 510, Div Nephrol, Madison, WI 53792 USA
[2] Vanderbilt Univ, Med Ctr, Dept Med, Div Nephrol, Nashville, TN USA
[3] Renal Care Grp Inc, Univ Div, Nashville, TN USA
关键词
hemodialysis; hospitalization; risk;
D O I
10.1159/000013521
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
Background/Aims: Hemodialysis (HD) patients are hospitalized more frequently than patients with other chronic diseases, averaging 11.5 hospital days/patient/year. Hospital costs attributable to renal failure in the US exceed $2 billion per year. The present healthcare climate continues to force dialysis providers to focus on these issues in order to optimize patient care while limiting cost. Methods: We used a novel method for analyzing hospitalization risk, a multiple-event Cox proportional hazards model, to identify factors that influenced hospitalization in a HD unit population over a two-year period. This model allows individual patients to contribute multiple failure events to the model while controlling for the serial dependency of events. Results: 178 HD patients were retrospectively examined. There were 381 hospitalizations during the study period, averaging out to 1.9 hospitalizations and 10.5 hospital days/patient-year. Substance abuse and diabetes conveyed the largest risks for hospitalization (diabetes RR: 2.09; substance abuse RR: 2.24) in the study cohort, exposing the necessity for examining practice patterns and behavioral interventions as means for improving HD patient care. Conclusion: Despite the small numbers of patients in this single-center HD population, the model achieved adequate statistical power. Therefore, it has the potential to serve as a continuous quality improvement (CQI) tool in particular HD patient sub-groups, or in individual HD units. Copyright (C) 1999 S. Karger AG. Basel.
引用
收藏
页码:565 / 570
页数:6
相关论文
共 18 条
  • [1] BERGSTRALH E, 1984, BIOMETRICS, V40, P493
  • [2] CANADIAN HEMODIALYSIS MORBIDITY STUDY
    CHURCHILL, DN
    TAYLOR, DW
    COOK, RJ
    LAPLANTE, P
    BARRE, P
    CARTIER, P
    FAY, WP
    GOLDSTEIN, MB
    JINDAL, K
    MANDIN, H
    MCKENZIE, JK
    MUIRHEAD, N
    PARFREY, PS
    POSEN, GA
    SLAUGHTER, D
    ULAN, RA
    WERB, R
    [J]. AMERICAN JOURNAL OF KIDNEY DISEASES, 1992, 19 (03) : 214 - 234
  • [3] CHURCHILL DN, 1995, CLIN NEPHROL, V43, P183
  • [4] Impact of hypertension on cardiomyopathy, morbidity and mortality in end-stage renal disease
    Foley, RN
    Parfrey, PS
    Harnett, JD
    Kent, GM
    Murray, DC
    Barre, PE
    [J]. KIDNEY INTERNATIONAL, 1996, 49 (05) : 1379 - 1385
  • [5] EFFECTS OF DOSE OF DIALYSIS ON MORBIDITY AND MORTALITY
    HAKIM, RM
    BREYER, J
    ISMAIL, N
    SCHULMAN, G
    [J]. AMERICAN JOURNAL OF KIDNEY DISEASES, 1994, 23 (05) : 661 - 669
  • [6] Jones K R, 1992, Image J Nurs Sch, V24, P88
  • [7] THE ROBUST INFERENCE FOR THE COX PROPORTIONAL HAZARDS MODEL
    LIN, DY
    WEI, LJ
    [J]. JOURNAL OF THE AMERICAN STATISTICAL ASSOCIATION, 1989, 84 (408) : 1074 - 1078
  • [8] COX REGRESSION-ANALYSIS OF MULTIVARIATE FAILURE TIME DATA - THE MARGINAL APPROACH
    LIN, DY
    [J]. STATISTICS IN MEDICINE, 1994, 13 (21) : 2233 - 2247
  • [9] EFFECT OF THE HEMODIALYSIS PRESCRIPTION ON PATIENT MORBIDITY - REPORT FROM THE NATIONAL COOPERATIVE DIALYSIS STUDY
    LOWRIE, EG
    LAIRD, NM
    PARKER, TF
    SARGENT, JA
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 1981, 305 (20) : 1176 - 1181
  • [10] Improving the care of patients treated with hemodialysis: A report from the health care financing administration's ESRD Core Indicators Project
    McClellan, WM
    Soucie, JM
    Krisher, J
    Caruana, R
    Haley, W
    Farmer, C
    [J]. AMERICAN JOURNAL OF KIDNEY DISEASES, 1998, 31 (04) : 584 - 592